Search Results - "Bochicchio, A.M."

1245 Zoledronic acid and Taxotere (ZANTE) metronomic and sequential administration in patients with hormone refractory prostate cancer (HRPC) – final results of phase I study by Caraglia, M, Morabito, A, Marra, M, Bochicchio, A.M, Piccirillo, M.C, Franco, R, Perrone, F, Budillon, A, Iaffaioli, R.V, Facchini, G

Get full text

6510 Sequential therapy with FOLFIRI followed by docetaxel plus cisplatin: a promising adjuvant chemotherapy in gastric adenocarcinoma. 5-year follow-up results of the I.T.M.O. Group study by Bartolomeo, M. Di, Buzzoni, R, Lo Vullo, S, Ferrario, E, Manzoni, M, Gevorgyan, A, Bochicchio, A.M, Cordio, S, Ardizzoni, A, Bajetta, E

Get full text

“TRAP1 7-protein signature” predicts clinical outcome in human metastatic colorectal carcinoma by Maddalena, F., Simeon, V., Vita, G., Bochicchio, A.M., Aieta, M., Esposito, F., Landriscina, M.

Get full text

Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network by Stacchiotti, S., Palassini, E., Sanfilippo, R., Vincenzi, B., Arena, M.G., Bochicchio, A.M., De Rosa, P., Nuzzo, A., Turano, S., Morosi, C., Dei Tos, A.P., Pilotti, S., Casali, P.G.

“…Angiosarcoma is a highly aggressive soft tissue sarcoma. Responses to anthracyclines plus/minus ifosfamide, and taxanes alone or in combination with…”
Get full text

Clinical impact of mucinous and poorly differentiated tumours on the outcome of patients with stage II colon cancer: A TOSCA subgroup analysis by Rosati, G., Galli, F., Cantore, M., Lonardi, S., Banzi, M., Zampino, M.G., Mattioli, R., Pella, N., Ronzoni, M., Bartolomeo, M Di, Tamberi, S., Marchetti, P., Bozzarelli, S., Corsi, D.C., Bochicchio, A.M., Artioli, F., Labianca, R., Bilancia, D., Bregni, G.

Get full text

551P - Clinical impact of mucinous and poorly differentiated tumours on the outcome of patients with stage II colon cancer: A TOSCA subgroup analysis by Rosati, G., Galli, F., Cantore, M., Lonardi, S., Banzi, M., Zampino, M.G., Mattioli, R., Pella, N., Ronzoni, M., Bartolomeo, M Di, Tamberi, S., Marchetti, P., Bozzarelli, S., Corsi, D.C., Bochicchio, A.M., Artioli, F., Labianca, R., Galli, F., Bilancia, D., Bregni, G.

“…ASCO and ESMO guidelines have identified inadequate sampling of lymph nodes, pT4 primary tumors, obstruction or perforation, lymphovascular and perineural…”
Get full text

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer by Bajetta, E., Labianca, R., Di Costanzo, F., Amadori, D., Carlomagno, C., Nitti, D., Daniele, B., Boni, C., Bidoli, P., Rosati, G., Di Fabio, F., Aitini, E., Floriani, I., Rulli, E., Galli, F., Tonato, M., Zucca, E., Bajetta, E., Amadori, D., Falcone, A., Di Costanzo, F., Daniele, B., Pinto, C., Mini, E., De Placido, S., Marchet, A., Schiavo, M., Proserpio, I., Rosati, G., Burrafato, G., Aieta, M., Fazio, N., Marini, G., Soto Parra, H., Novello, G., Massidda, B., Comandè, M., Bertolini, A., Zanlorenzi, L., Colombo, A., Iop, A., Bonura, S., Mazza, E., Viganò, M., Lo Re, G., Buonadonna, A., Luisi, D., Marchetti, P., Corsi, D.C., Oliani, C., Inzoli, A., Gebbia, N., Repetto, L., Rota, S., Quadri, A., Foa, P., Petrelli, F., Luchena, G., Nasisi, A., Catalano, V., Giordani, P., Zaniboni, A., Conte, D., Giannicola, R., Luporini, A.G., Ravaioli, A., Tassinari, D., Nicolini, M., Turci, D., Zumaglini, F., Landi, L., Minuti, G., Cantore, M., Del Monte, F., Lencioni, M., Sisani, M., Granetto, C., Chiara, S., Ribecco, A.S., Baldini, E.E., Camisa, R., Todeschini, R., Rondini, E., Gnoni, R., Cavanna, L., Alessio, M.D., Tomasello, G., Giaquinta, S., Brandes, A.A., Casaretti, R., Sarobba, M.G., Sanna, G., Greco, E., Condemi, G., de Manzoni, G., Fiorentini, G., Carlomagno, C., De Stefano, A., Cartenì, G., Otero, M.

“…Some trial have demonstrated a benefit of adjuvant fluoropirimidine with or without platinum compounds compared with surgery alone. ITACA-S study was designed…”
Get full text

Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial by Galli, Fabio, Di Bartolomeo, Maria, Ronzoni, Monica, Banzi, Maria, Pasini, Felice, Bozzarelli, Silvia, Ferrari, Daris, Montesarchio, Vincenzo, Mambrini, Andrea, Ciuffreda, Libero, Pusceddu, Valeria, Carlomagno, Chiara, Bidoli, Paolo, Amoroso, Domenico, Frassineti, Luca, Pastorino, Alessandro, De Stefano, Alfonso, Labianca, Roberto, Rosati, G., Montesarchio, V., Iaffaioli, R.V., Nasti, G., Daniele, B., Lonardi, S., Pella, N., Marchetti, Roma P., Romiti, A., Foa, P., Zaniboni, A., Labianca, R., Mosconi, S., Sobrero, A., Bidoli, P., Cazzaniga, M., Beretta, G.D., Corsi, D.C., Cortesi, E., Barni, S., Petrelli, F., Allione, P., D'Arco, A.M., Valmadre, G., Piazza, E., Veltri, E., Tumulo, S., Cascinu, S., Granetto, C., Giordano, M., Moroni, M., Di Seri, M., Nuzzo, A., Gori, S., Aglietta, M., Tonini, G., Benasso, M., Graiff, C., Bravi, S., Frontini, L., Rota, S., Cozzi, L., Cantore, M., Maiello, E., Cinieri, S., Romito, S., Gebbia, V., Santoro, A., Artioli, F., Mattioli, R., Contu, A., Di Costanzo, F., Leonardi, F., Passalacqua, R., Sozzi, P., D'Amico, M., Pasquini, E., Gambi, A., Faedi, M., Cruciani, G., Bajetta, E., Gianni, L., Ronzoni, M., Massidda, B., Scartozzi, M., Zampino, M.G., Bochicchio, A.M., Frustaci, S., Pavesi, L., Verusio, C., Pinotti, G., Iop, A., De Placido, S., Carlomagno, C., Adamo, V., Ficorella, C., Greco, E., Rulli, E., Galli, F., Poli, D., Porcu, L., Torri, V.

“…Previous studies on oxaliplatin and fluoropyrimidines as adjuvant therapy in older patients with stage III colon cancer (CC) produced conflicting results. We…”
Get full text

Phase II open-label single-arm study of pre-operative panitumumab and external pelvic radiotherapy (RTE) in locally advanced rectal cancer (LARC) patients (pts) (RaP/STAR-03 Study) by Pinto, C., Di Bisceglie, M., Di Fabio, F., Bochicchio, A.M., Latiano, T., Cordio, S., Rosati, G., Aschele, C., Marino, A., Bergamo, F., Bustreo, S., Frassineti, L., Ciardiello, F., Giaquinta, S., Baldari, D., Boni, L.

Get full text

O-019 Distant-relapse analysis of STAR-01, a randomized phase III trial comparing preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer by Lonardi, S., Cionini, L., Pinto, C., Cordio, S., Rosati, G., Sartore Bianchi, A., Tagliagambe, A., Frisinghelli, M., Zagonel, V., Rosetti, P., Negru, M.E., Bonetti, A., Tronconi, M.C., Luppi, G., Marsella, A.R., Corsi, C., Bochicchio, A.M., Aprile, G., Niespolo, R., Granetto, C., Boni, L., Aschele, C.

Get full text

A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group by Di Bartolomeo, M, Bajetta, E, Bochicchio, A M, Carnaghi, C, Somma, L, Mazzaferro, V, Visini, M, Gebbia, V, Tumolo, S, Ballatore, P

“…Previous experiences in the treatment of neuroendocrine tumours have demonstrated some activity of single agents such as adriamycin, fluorouracil (FU),…”
Get more information

Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: the experience of the National Cancer Institute of Milan by Colleoni, M, Bajetta, E, Nelli, P, Boni, L, Bochicchio, A M, Nolè, F, Buzzoni, R, Celio, L, Mazzaferro, V, Bonfanti, G

“…Survival times and overall response rates are generally poor in patients with unresectable hepatocellular carcinoma submitted to systemic chemotherapy. Limited…”
Get more information

Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group by Bajetta, E, Di Bartolomeo, M, de Braud, F, Bozzetti, F, Bochicchio, A M, Comella, P, Fagnani, D, Farina, G, Ferroni, C, Franchi, R

“…Various reports have documented the efficacy of the combination of etoposide, doxorubicin and cisplatin (EAP) in the treatment of advanced gastric cancer,…”
Get more information